SEC Form D · filed July 2, 2024
DiaMedica Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Tanya N. Lewis · Minneapolis, MNDirectorR. M. Giuffre · Minneapolis, MNDirectorRichard D. Pilnik · Minneapolis, MNDirectorCharles P. Semba · Minneapolis, MNDirectorDavid J. Wambeke · Minneapolis, MNExecScott Kellen · Minneapolis, MNExecJames T. Parsons · Minneapolis, MNDirectorRick Pauls · Minneapolis, MNExec · DirectorRichard M. Kuntz · Minneapolis, MNDirectorCharles Phillips · New York, NYDirectorKevin Ashton · Lindon, UTDirectorJ.W.G. W. Honeybourne · Stamford, CTDirectorTodd M. Tomlin · Stamford, CTExec · DirectorDavid Wasserman · New York, NYDirectorJens Ashton · Provo, UTDirectorJeffrey K. Quake · Stamford, CTExecPatrick J. Carrol · Stamford, CTExecFrancisco D'Souza · New York, NYDirectorLorianne Masuoka · Minneapolis, MNExecEdward C. Atsinger · Camarillo, CAExecDavid P. Santrella · Camatillo, CAExecCurtis Burgess · Madison, WIDirectorMatthew Kirk · San Rafael, CAExec · DirectorMichael T. Roth · Greenville, SCDirectorKevin M. Short · Greenville, SCDirectorMartin A. Burian · Vancouver, British Columbia, CanadaDirectorRandy D. Ginn · Bellevue, WADirectorTimothy R. D'Arcy · Boston, MADirectorLorianne Masuoka · Minneapolis, MNExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗